You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0261 Outcomes in Systemic Lupus Erythematous (SLE) Patients with High Disease Activity Treated with Belimumab: Results from an Observational Study in the United States (U.S.)

Article metrics

Article menu
Download PDFPDF
Poster Presentation
SLE, Sjögren’s and APS - treatment
THU0261 Outcomes in Systemic Lupus Erythematous (SLE) Patients with High Disease Activity Treated with Belimumab: Results from an Observational Study in the United States (U.S.)

 

Online download statistics by month:

Online download statistics by month: February 2014 to January 2024

AbstractFullPdf
Feb 20141200
Apr 2014800
May 2014901
Jun 2014502
Jul 2014400
Aug 2014300
Sep 2014301
Oct 2014700
Nov 2014601
Dec 2014200
Jan 2015300
Feb 2015201
Mar 2015401
Apr 20151001
Jun 2015100
Jul 2015300
Aug 2015400
Sep 2015800
Oct 2015001
Nov 2015503
Jan 2016400
Feb 2016301
Mar 2016200
Apr 2016200
May 20161801
Jun 2016300
Jul 2016600
Aug 2016200
Sep 2016800
Oct 2016400
Nov 2016400
Dec 2016500
Jan 2017700
Feb 2017100
Mar 2017300
Apr 2017400
May 2017500
Jun 2017400
Aug 2017800
Sep 2017600
Oct 2017400
Nov 20171200
Dec 2017400
Jan 2018600
Mar 20182000
Apr 20181400
May 20185401
Jun 20181200
Jul 20181000
Aug 2018600
Sep 2018600
Oct 2018400
Nov 2018200
Jan 2019400
Feb 2019400
Apr 2019200
Sep 2019200
Dec 2019200
Feb 2020200
May 2020200
Jul 2020401
Sep 2020800
Nov 2020400
Dec 2020401
Jan 2021200
Oct 2021400
Nov 20211400
Dec 20211000
Jan 2022200
Feb 2022400
Mar 2022200
May 2022400
Jul 20221400
Aug 2022400
Sep 2022200
Oct 2022400
Nov 2022200
Dec 2022600
Jan 20231600
Feb 2023400
Mar 2023400
Apr 2023400
May 2023600
Jun 2023200
Jul 2023200
Sep 2023600
Oct 2023200
Dec 20231400
Jan 20241600
Total540017